Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tombal BF"'
Autor:
Tombal BF; Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium. Electronic address: Bertrand.tombal@saintluc.uclouvain.be., Gomez-Veiga F; Complexo Hospitalario Universitario de A Coruña, Coruña, Spain., Gomez-Ferrer A; IVO, Valencia, Spain., López-Campos F; Hospital Universitario Ramón y Cajal, Madrid, Spain., Ost P; Ghent University Hospital, Ghent, Belgium., Roumeguere TA; Department of Urology, Hôpital Universitaire de Bruxelles Erasme Hospital, ULB, Anderlecht, Belgium., Herrera-Imbroda B; Hospital Universitario Virgen De La Victoria, Malaga, Spain., D'Hondt LA; CHU UCL NAMUR site Godinne, Yvoir, Belgium., Quivrin M; Radiation Oncology Department, Anticancer Center, Centre Georges Francois Leclerc, Dijon, France., Gontero P; Dipartimento di Discipline Medico Chirurgiche, Clinica Urologica, University of Torino, Torino, Italy., Villà S; Radiation Oncology, Department of Oncology, Badalona, Barcelona, Catalonia, Spain., Khaled H; National Cancer Institute, Cairo, Egypt., Fournier B; EORTC, Brussels, Belgium., Musoro J; EORTC, Brussels, Belgium., Krzystyniak J; EORTC, Brussels, Belgium., Pretzenbacher Y; National Cancer Institute, Cairo, Egypt., Loriot Y; Département de Médecine Oncologique, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Oct; Vol. 7 (5), pp. 1051-1060. Date of Electronic Publication: 2024 Jan 24.
Autor:
Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City., Saltzstein DR; Urology San Antonio, San Antonio, Texas., Tutrone R; Chesapeake Urology, Towson, Maryland., Bossi A; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France., Brown BA; Myovant Sciences Inc, Brisbane, California., Lu S; Myovant Sciences Inc, Brisbane, California., Fallick M; Myovant Sciences Inc, Brisbane, California., Hanson S; Pfizer Inc, New York, New York., Tombal BF; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602.
Autor:
Gonzalez JM; Department of Population Health Sciences, Duke University School of Medicine, 300 W. Morgan Street, 27701, Durham, NC, USA. jm.gonzalez@duke.edu.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. jm.gonzalez@duke.edu.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. jm.gonzalez@duke.edu., Ganguli A; Medical Affairs, Astellas Pharma Inc., Northbrook, IL, USA., Morgans AK; Dana-Farber Cancer Institute, Boston, MA, USA., Tombal BF; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Hotte SJ; Department of Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada., Suzuki H; Department of Urology, Toho University Sakura Medical Center, Sakura City, Chiba, Japan., Bhadauria H; Medical Affairs, Astellas Pharma Inc., Northbrook, IL, USA., Oh M; Medical Affairs, Astellas Pharma Inc., Northbrook, IL, USA., Scales CD Jr; Department of Population Health Sciences, Duke University School of Medicine, 300 W. Morgan Street, 27701, Durham, NC, USA.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Urology, Duke University School of Medicine, Durham, NC, USA., Wallace MJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Yang JC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., George DJ; Department of Population Health Sciences, Duke University School of Medicine, 300 W. Morgan Street, 27701, Durham, NC, USA.
Publikováno v:
The patient [Patient] 2023 Nov; Vol. 16 (6), pp. 607-623. Date of Electronic Publication: 2023 Aug 11.
Autor:
Stoevelaar H; Ismar Healthcare, Lier, Belgium., Bahl A; University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol, UK., Helsen N; Ismar Healthcare, Lier, Belgium., Michels NRM; Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Smets L; Ismar Healthcare, Lier, Belgium., Speakman MJ; International Society for the Study and Exchange of Evidence from Clinical Research and Medical Experience (ISSECAM), Lier, Belgium.; Department of Urology, Musgrove Park Hospital, Somerset Foundation Trust, Taunton, UK., Stranne J; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Sahlgrenska University Hospital-Västra Götaland, Gothenburg, Sweden., Toelen J; International Society for the Study and Exchange of Evidence from Clinical Research and Medical Experience (ISSECAM), Lier, Belgium.; Department of Development and Regeneration, Leuven, Belgium.; Department of Paediatrics, University Hospitals Leuven, Leuven, Belgium., Van der Aa F; Department of Development and Regeneration, Leuven, Belgium.; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Van Ruysevelt L; International Society for the Study and Exchange of Evidence from Clinical Research and Medical Experience (ISSECAM), Lier, Belgium.; e-HIMS, Lier, Belgium., Yperman J; Ismar Healthcare, Lier, Belgium., Zilli T; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland., Tombal BF; International Society for the Study and Exchange of Evidence from Clinical Research and Medical Experience (ISSECAM), Lier, Belgium.; Urology, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Michel MC; International Society for the Study and Exchange of Evidence from Clinical Research and Medical Experience (ISSECAM), Lier, Belgium.; Department of Pharmacology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Publikováno v:
Journal of European CME [J Eur CME] 2022 Nov 29; Vol. 11 (1), pp. 2153438. Date of Electronic Publication: 2022 Nov 29 (Print Publication: 2022).
Autor:
Tombal BF; Urology, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Freedland SJ; Urology, Center for Integrated Research in Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Durham VA Medical Center, Durham, NC, USA., Armstrong AJ; School of Medicine, Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA., Beer TM; Hematology/Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Stenzl A; Urology, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany., Sternberg CN; Englander Institute for Precision Medicine, Medical Oncology, Weill Cornell Medicine, Meyer Cancer Center, New York, NY, USA., Hussain M; Medicine, Lurie Cancer Center, Northwestern University, Chicago, IL, USA., Ganguli A; HEOR, Astellas Pharma Inc, Northbrook, IL, USA., Ramaswamy K; HEOR, Pfizer Inc, New York, NY, USA., Bhadauria H; Medical Affairs, Astellas Pharma Inc., Northbrook, IL, USA., Ivanescu C; Statistics, IQVIA, Amsterdam-Zuidoost, the Netherlands., Turnbull J; Patient Centered Endpoints, IQVIA, New York, NY, USA., Holmstrom S; HEOR, Astellas Pharma Inc., Leiden, the Netherlands., Saad F; Urology, University of Montréal Hospital Center, Montréal, QC, Canada. fred.saad@umontreal.ca.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Feb; Vol. 25 (2), pp. 288-295. Date of Electronic Publication: 2021 Sep 13.
Autor:
Terrisse S; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.; Université Paris Sud, Orsay, France.; INSERM U1015, Université Paris Sud, Orsay, France., Karamouza E; Université Paris Sud, Orsay, France.; Ligue Nationale Contre le Cancer Meta-Analysis Platform, Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France., Parker CC; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Institute of Cancer Research, Sutton, United Kingdom., Sartor AO; Tulane University School of Medicine, New Orleans, Louisiana., James ND; Institute of Cancer and Genomic Sciences, University Hospitals Birmingham, Birmingham, United Kingdom., Pirrie S; Institute of Cancer and Genomic Sciences, University Hospitals Birmingham, Birmingham, United Kingdom., Collette L; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Tombal BF; Cliniques Universitaires Saint Luc, Brussels, Belgium., Chahoud J; The University of Texas MD Anderson Cancer Center, Houston., Smeland S; Division of Cancer Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway., Erikstein B; Division of Cancer Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway., Pignon JP; Université Paris Sud, Orsay, France.; Ligue Nationale Contre le Cancer Meta-Analysis Platform, Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France.; CESP, Faculté de médecine, Université Paris Sud, Faculté de médecine, INSERM U1018, Université Paris Saclay, Villejuif, France., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.; Université Paris Sud, Orsay, France., Le Teuff G; Université Paris Sud, Orsay, France.; Ligue Nationale Contre le Cancer Meta-Analysis Platform, Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France.; CESP, Faculté de médecine, Université Paris Sud, Faculté de médecine, INSERM U1018, Université Paris Saclay, Villejuif, France.
Publikováno v:
JAMA oncology [JAMA Oncol] 2020 Feb 01; Vol. 6 (2), pp. 206-216.
Autor:
Saad F; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Sternberg CN; Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy., Mulders PFA; Radboud University Medical Centre, Nijmegen, Netherlands., Niepel D; Amgen (Europe) GmbH, Zug, Switzerland., Tombal BF; Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: Bertrand.Tombal@uclouvain.be.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2018 Jul; Vol. 68, pp. 25-37. Date of Electronic Publication: 2018 May 03.
Autor:
Tombal BF; Service d'Urologie, Centre du Cancer, Institut de Recherche Clinique, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Van Nieuwenhove S; Service d'Radiologie, Centre du Cancer, Institut de Recherche Clinique, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Lecouvet FE; Service d'Radiologie, Centre du Cancer, Institut de Recherche Clinique, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
Publikováno v:
JAMA oncology [JAMA Oncol] 2015 Sep; Vol. 1 (6), pp. 831-2.